Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-012-1257-x.

Title:
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer | Cancer Immunology, Immunotherapy
Description:
Radiation therapy (RT) is an integral part of prostate cancer treatment across all stages and risk groups. Immunotherapy using a live, attenuated, Listeria monocytogenes-based vaccines have been shown previously to be highly efficient in stimulating anti-tumor responses to impact on the growth of established tumors in different tumor models. Here, we evaluated the combination of RT and immunotherapy using Listeria monocytogenes-based vaccine (ADXS31-142) in a mouse model of prostate cancer. Mice bearing PSA-expressing TPSA23 tumor were divided to 5 groups receiving no treatment, ADXS31-142, RT (10 Gy), control Listeria vector and combination of ADXS31-142 and RT. Tumor growth curve was generated by measuring the tumor volume biweekly. Tumor tissue, spleen, and sera were harvested from each group for IFN-γ ELISpot, intracellular cytokine assay, tetramer analysis, and immunofluorescence staining. There was a significant tumor growth delay in mice that received combined ADXS31-142 and RT treatment as compared with mice of other cohorts and this combined treatment causes complete regression of their established tumors in 60 % of the mice. ELISpot and immunohistochemistry of CD8+ cytotoxic T Lymphocytes (CTL) showed a significant increase in IFN-γ production in mice with combined treatment. Tetramer analysis showed a fourfold and a greater than 16-fold increase in PSA-specific CTLs in animals receiving ADXS31-142 alone and combination treatment, respectively. A similar increase in infiltration of CTLs was observed in the tumor tissues. Combination therapy with RT and Listeria PSA vaccine causes significant tumor regression by augmenting PSA-specific immune response and it could serve as a potential treatment regimen for prostate cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, google, scholar, pubmed, cancer, cas, prostate, vaccine, tumor, immunotherapy, listeria, psa, radiation, cells, therapy, immunol, oncol, treatment, radiotherapy, clin, antigen, paterson, int, combined, response, tumors, med, schlom, res, monocytogenes, combination, mice, cell, patients, phase, hodge, immunother, analysis, wallecha, guha, vaccines, antitumor, growth, ctl, access, biol, study, human, prostatespecific, chen,

Topics {✒️}

hla-a2-restricted ny-eso-1b peptide poxviral-based psa-targeted immunotherapy spontaneous cd8+ t-cell response vaccine-mediated t-cell killing listeria monocytogenes-based vaccines psa-specific cd8+ ctl responses month download article/chapter stimulating anti-tumor responses long-term prognostic significance radiation-induced ifn-gamma production castration-resistant prostate cancer related subjects listeria monocytogenes-based vaccine total prostate-specific antigen therapeutic cancer vaccines reshma singh & john rothman article cancer immunology uvc light-induced apoptosis intermediate-risk prostate cancer listeria monocytogenes enhances dose-escalation study localized prostate cancer full article pdf long-term results e7 induce qualitatively lm-llo-e7 recombinant canarypox virus immune response targeting restricted ctl epitope randomized controlled trial prostate specific antigen prostate-specific antigen human papilloma virus-16 privacy choices/manage cookies recombinant cancer vaccine listeria psa vaccine broad antitumor response cell activating therapy tumor-bearing hosts radiation therapy leads synergizing radiation therapy local radiation therapy external beam radiation metastatic lung cancer metastatic prostate tumors listeria-induced macrophages current vaccination strategies advanced prostate cancer prostate cancer recurrence tumors alters phenotype

Questions {❓}

  • Dasu A (2007) Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?
  • Fowler J, Chappell R, Ritter M (2001) Is alpha/beta for prostate tumors really low?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
         description:Radiation therapy (RT) is an integral part of prostate cancer treatment across all stages and risk groups. Immunotherapy using a live, attenuated, Listeria monocytogenes-based vaccines have been shown previously to be highly efficient in stimulating anti-tumor responses to impact on the growth of established tumors in different tumor models. Here, we evaluated the combination of RT and immunotherapy using Listeria monocytogenes-based vaccine (ADXS31-142) in a mouse model of prostate cancer. Mice bearing PSA-expressing TPSA23 tumor were divided to 5 groups receiving no treatment, ADXS31-142, RT (10 Gy), control Listeria vector and combination of ADXS31-142 and RT. Tumor growth curve was generated by measuring the tumor volume biweekly. Tumor tissue, spleen, and sera were harvested from each group for IFN-γ ELISpot, intracellular cytokine assay, tetramer analysis, and immunofluorescence staining. There was a significant tumor growth delay in mice that received combined ADXS31-142 and RT treatment as compared with mice of other cohorts and this combined treatment causes complete regression of their established tumors in 60 % of the mice. ELISpot and immunohistochemistry of CD8+ cytotoxic T Lymphocytes (CTL) showed a significant increase in IFN-γ production in mice with combined treatment. Tetramer analysis showed a fourfold and a greater than 16-fold increase in PSA-specific CTLs in animals receiving ADXS31-142 alone and combination treatment, respectively. A similar increase in infiltration of CTLs was observed in the tumor tissues. Combination therapy with RT and Listeria PSA vaccine causes significant tumor regression by augmenting PSA-specific immune response and it could serve as a potential treatment regimen for prostate cancer.
         datePublished:2012-05-27T00:00:00Z
         dateModified:2012-05-27T00:00:00Z
         pageStart:2227
         pageEnd:2238
         sameAs:https://doi.org/10.1007/s00262-012-1257-x
         keywords:
            Radiation therapy
            Listeria PSA vaccine
            Immunotherapy
            Prostate cancer
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig5_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:61
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Raquibul Hannan
               affiliation:
                     name:UT Southwestern Medical Center
                     address:
                        name:Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huagang Zhang
               affiliation:
                     name:Montefiore Medical Centre
                     address:
                        name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anu Wallecha
               affiliation:
                     name:Advaxis Inc.
                     address:
                        name:Advaxis Inc., Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Reshma Singh
               affiliation:
                     name:Advaxis Inc.
                     address:
                        name:Advaxis Inc., Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laibin Liu
               affiliation:
                     name:Montefiore Medical Centre
                     address:
                        name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patrice Cohen
               affiliation:
                     name:Montefiore Medical Centre
                     address:
                        name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alan Alfieri
               affiliation:
                     name:Montefiore Medical Centre
                     address:
                        name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John Rothman
               affiliation:
                     name:Advaxis Inc.
                     address:
                        name:Advaxis Inc., Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chandan Guha
               affiliation:
                     name:Montefiore Medical Centre
                     address:
                        name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                        type:PostalAddress
                     type:Organization
                     name:Montefiore Medical Center
                     address:
                        name:Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
      description:Radiation therapy (RT) is an integral part of prostate cancer treatment across all stages and risk groups. Immunotherapy using a live, attenuated, Listeria monocytogenes-based vaccines have been shown previously to be highly efficient in stimulating anti-tumor responses to impact on the growth of established tumors in different tumor models. Here, we evaluated the combination of RT and immunotherapy using Listeria monocytogenes-based vaccine (ADXS31-142) in a mouse model of prostate cancer. Mice bearing PSA-expressing TPSA23 tumor were divided to 5 groups receiving no treatment, ADXS31-142, RT (10 Gy), control Listeria vector and combination of ADXS31-142 and RT. Tumor growth curve was generated by measuring the tumor volume biweekly. Tumor tissue, spleen, and sera were harvested from each group for IFN-γ ELISpot, intracellular cytokine assay, tetramer analysis, and immunofluorescence staining. There was a significant tumor growth delay in mice that received combined ADXS31-142 and RT treatment as compared with mice of other cohorts and this combined treatment causes complete regression of their established tumors in 60 % of the mice. ELISpot and immunohistochemistry of CD8+ cytotoxic T Lymphocytes (CTL) showed a significant increase in IFN-γ production in mice with combined treatment. Tetramer analysis showed a fourfold and a greater than 16-fold increase in PSA-specific CTLs in animals receiving ADXS31-142 alone and combination treatment, respectively. A similar increase in infiltration of CTLs was observed in the tumor tissues. Combination therapy with RT and Listeria PSA vaccine causes significant tumor regression by augmenting PSA-specific immune response and it could serve as a potential treatment regimen for prostate cancer.
      datePublished:2012-05-27T00:00:00Z
      dateModified:2012-05-27T00:00:00Z
      pageStart:2227
      pageEnd:2238
      sameAs:https://doi.org/10.1007/s00262-012-1257-x
      keywords:
         Radiation therapy
         Listeria PSA vaccine
         Immunotherapy
         Prostate cancer
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1257-x/MediaObjects/262_2012_1257_Fig5_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:61
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Raquibul Hannan
            affiliation:
                  name:UT Southwestern Medical Center
                  address:
                     name:Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huagang Zhang
            affiliation:
                  name:Montefiore Medical Centre
                  address:
                     name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anu Wallecha
            affiliation:
                  name:Advaxis Inc.
                  address:
                     name:Advaxis Inc., Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Reshma Singh
            affiliation:
                  name:Advaxis Inc.
                  address:
                     name:Advaxis Inc., Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laibin Liu
            affiliation:
                  name:Montefiore Medical Centre
                  address:
                     name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patrice Cohen
            affiliation:
                  name:Montefiore Medical Centre
                  address:
                     name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alan Alfieri
            affiliation:
                  name:Montefiore Medical Centre
                  address:
                     name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John Rothman
            affiliation:
                  name:Advaxis Inc.
                  address:
                     name:Advaxis Inc., Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chandan Guha
            affiliation:
                  name:Montefiore Medical Centre
                  address:
                     name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
                     type:PostalAddress
                  type:Organization
                  name:Montefiore Medical Center
                  address:
                     name:Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:61
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:UT Southwestern Medical Center
      address:
         name:Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA
         type:PostalAddress
      name:Montefiore Medical Centre
      address:
         name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
         type:PostalAddress
      name:Advaxis Inc.
      address:
         name:Advaxis Inc., Princeton, USA
         type:PostalAddress
      name:Advaxis Inc.
      address:
         name:Advaxis Inc., Princeton, USA
         type:PostalAddress
      name:Montefiore Medical Centre
      address:
         name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
         type:PostalAddress
      name:Montefiore Medical Centre
      address:
         name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
         type:PostalAddress
      name:Montefiore Medical Centre
      address:
         name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
         type:PostalAddress
      name:Advaxis Inc.
      address:
         name:Advaxis Inc., Princeton, USA
         type:PostalAddress
      name:Montefiore Medical Centre
      address:
         name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
         type:PostalAddress
      name:Montefiore Medical Center
      address:
         name:Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Raquibul Hannan
      affiliation:
            name:UT Southwestern Medical Center
            address:
               name:Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA
               type:PostalAddress
            type:Organization
      name:Huagang Zhang
      affiliation:
            name:Montefiore Medical Centre
            address:
               name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
               type:PostalAddress
            type:Organization
      name:Anu Wallecha
      affiliation:
            name:Advaxis Inc.
            address:
               name:Advaxis Inc., Princeton, USA
               type:PostalAddress
            type:Organization
      name:Reshma Singh
      affiliation:
            name:Advaxis Inc.
            address:
               name:Advaxis Inc., Princeton, USA
               type:PostalAddress
            type:Organization
      name:Laibin Liu
      affiliation:
            name:Montefiore Medical Centre
            address:
               name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
               type:PostalAddress
            type:Organization
      name:Patrice Cohen
      affiliation:
            name:Montefiore Medical Centre
            address:
               name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
               type:PostalAddress
            type:Organization
      name:Alan Alfieri
      affiliation:
            name:Montefiore Medical Centre
            address:
               name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
               type:PostalAddress
            type:Organization
      name:John Rothman
      affiliation:
            name:Advaxis Inc.
            address:
               name:Advaxis Inc., Princeton, USA
               type:PostalAddress
            type:Organization
      name:Chandan Guha
      affiliation:
            name:Montefiore Medical Centre
            address:
               name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
               type:PostalAddress
            type:Organization
            name:Montefiore Medical Center
            address:
               name:Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA
      name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
      name:Advaxis Inc., Princeton, USA
      name:Advaxis Inc., Princeton, USA
      name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
      name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
      name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
      name:Advaxis Inc., Princeton, USA
      name:Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Centre, Bronx, USA
      name:Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(258)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.16s.